Post-approval studies (Phase 4)Study completedNCT00168545What this trial is testingImmunology of Non-specific Effects of VaccineWho this might be right forMeaslesDiphtheriaTetanus+1 more Bandim Health Project 400
Large-scale testing (Phase 3)Study completedNCT03713359What this trial is testingClinical Trial for Measles - Rubella Combined Vaccine (MRVAC) Produced by POLYVAC (Phase III)Who this might be right forSigns and Symptoms Center for Research and Production of Vaccines and Biologicals, Vietnam 756
Post-approval studies (Phase 4)Study completedNCT03680417What this trial is testingReactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and ChildrenWho this might be right forSafety IssuesImmunogenicity PT Bio Farma 590
Early research (Phase 1)Study completedNCT04497298What this trial is testingClinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 VaccineWho this might be right forCOVID-19 Institut Pasteur 90
Post-approval studies (Phase 4)Study completedNCT00463684What this trial is testingLive Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of AgeWho this might be right forJapanese Encephalitis PATH 278
Large-scale testing (Phase 3)Study completedNCT00249769What this trial is testingDetermining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles VaccineWho this might be right forEncephalitis, Japanese B PATH 600
Large-scale testing (Phase 3)Study completedNCT00985166What this trial is testingProQuad in Healthy 4 to 6 Year Old Children (V221-014)Who this might be right forMeaslesMumpsRubella+1 more Merck Sharp & Dohme LLC 801
Testing effectiveness (Phase 2)Study completedNCT00436007What this trial is testingSafety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI RegimenWho this might be right forMalaria GlaxoSmithKline 511
Post-approval studies (Phase 4)Study completedNCT03780179What this trial is testingMMR at 6 Months TrialWho this might be right forMeales-mumps-rubella Vaccine Rigshospitalet, Denmark 6,540
Not applicableStudy completedNCT02151773What this trial is testingFreeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First VaccinationWho this might be right forMeasles/Rubella Takeda 3,493
Not applicableStudy completedNCT00156559What this trial is testingMMR and Varicella Vaccine in Premature InfantsWho this might be right forChickenpoxRubellaRubeola+1 more University of Rochester 32
Large-scale testing (Phase 3)Study completedNCT00197015What this trial is testingImmunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in ChildrenWho this might be right forHepatitis A GlaxoSmithKline 1,474
Early research (Phase 1)Study completedNCT01320176What this trial is testingStudy to Evaluate the Dosage and Safety of Two Intramuscular Injections of an Investigational Clade B HIV VaccineWho this might be right forHIV Institut Pasteur 36
Large-scale testing (Phase 3)Study completedNCT00871117What this trial is testingImmunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 YearsWho this might be right forTetanusAcellular PertussisDiphtheria GlaxoSmithKline 478
Not applicableStudy completedNCT07373093What this trial is testingPredictors of Measles Vaccine Hesitancy in New York StateWho this might be right forMeasles Vaccination Albany Medical College 99
Post-approval studies (Phase 4)Looking for participantsNCT05758532What this trial is testingNon-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in ChildrenWho this might be right forRespiratory Tract InfectionsInfectionsAllergy+1 more Laure Pittet, MD-PhD 500
Post-approval studies (Phase 4)Study completedNCT04111432What this trial is testingSafety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization VaccinesWho this might be right forHand, Foot and Mouth Disease Sinovac Biotech Co., Ltd 372
Post-approval studies (Phase 4)Study completedNCT00388440What this trial is testingAssess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.Who this might be right forRubellaMumpsMeasles GlaxoSmithKline 150
Large-scale testing (Phase 3)Study completedNCT04183114What this trial is testingImmunogenicity & Safety of Bio Farma's Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study)Who this might be right forCongenital Rubella InfectionMeasles PT Bio Farma 540
Post-approval studies (Phase 4)Study completedNCT00312858What this trial is testingConcomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)Who this might be right forHepatitis A Virus Merck Sharp & Dohme LLC 653